182917834	182917834	CD	B-NP	O
|	|	NN	I-NP	O
MH	MH	NN	I-NP	O
|	|	NN	I-NP	O
13395565	13395565	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
506849	506849	CD	B-NP	O
|	|	CC	I-NP	O
5/23/1999	5/23/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
ISCHEMIA	ISCHEMIA	NNP	I-NP	O
RT.	RT.	NNP	I-NP	O
.	.	.	O	O

LEG	LEG	NNP	B-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/2/1999	9/2/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/27/1999	8/27/1999	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
68	68	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
non-insulin	non-insulin	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
revascularization	revascularization	NN	I-NP	O
procedure	procedure	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
his	his	PRP$	B-NP	O
foot	foot	NN	I-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
cool	cool	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
graft	graft	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
occluded	occlude	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presents	present	VBZ	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
re-operation	re-operation	NN	I-NP	O
for	for	IN	B-PP	O
revascularization	revascularization	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Non-insulin	Non-insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
and	and	CC	O	O
series	series	NN	B-NP	O
of	of	IN	B-PP	O
angioplasties	angioplasty	NNS	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
.	.	.	O	O

Gastroesophageal	Gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Non-healing	Non-healing	JJ	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Glucophage	Glucophage	NN	B-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Simvastatin	Simvastatin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NPH	NPH	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
PAST	PAST	NN	I-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
1991	1991	CD	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
only	only	RB	B-ADVP	O
by	by	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
medically	medically	RB	I-VP	O
managed	manage	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
without	without	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
superficial	superficial	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-PP	O
anterior	anterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
with	with	IN	B-PP	O
non-reversed	non-reversed	JJ	B-NP	O
greater	great	JJR	I-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
common	common	JJ	B-NP	O
femoral	femoral	JJ	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
with	with	IN	B-PP	O
Dacron	Dacron	NN	B-NP	O
patch	patch	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
foot	foot	NN	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
this	this	DT	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
uncomplicated	uncomplicated	JJ	I-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
quit	quit	VBD	B-VP	O
smoking	smoking	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
angina	angina	NN	B-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
bypass	bypass	NN	I-NP	O
.	.	.	O	O

Just	Just	RB	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Frankie	Frankie	NNP	I-NP	O
Krampitz	Krampitz	NNP	I-NP	O
of	of	IN	B-PP	O
Harlsti	Harlsti	NNP	B-NP	O
Conon	Conon	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
saying	say	VBG	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
average	average	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
well	well	RB	B-ADVP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
surgeries	surgery	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
preoperative	preoperative	JJ	I-NP	O
angiogram	angiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
his	his	PRP$	B-NP	O
superficial	superficial	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
artery	artery	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
proximally	proximally	RB	I-VP	O
occluded	occlude	VBN	I-VP	O
with	with	IN	B-PP	O
mid	mid	NN	B-NP	O
to	to	TO	B-PP	O
distal	distal	JJ	B-NP	O
reconstitution	reconstitution	NN	I-NP	O
.	.	.	O	O

Above	Above	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
popliteal	popliteal	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Below	Below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
popliteal	popliteal	NN	I-NP	O
was	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
proximal	proximal	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
peroneal	peroneal	JJ	I-NP	O
and	and	CC	I-NP	O
posterior	posterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
occludes	occlude	NNS	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
high	high	JJ	B-NP	O
grade	grade	NN	I-NP	O
focal	focal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
is	be	VBZ	B-VP	O
patent	patent	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
2/10/99	2/10/99	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
where	where	WRB	B-ADVP	O
Dr.	Dr.	NNP	B-NP	O
Moises	Moises	NNP	I-NP	O
performed	perform	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
above-the-knee	above-the-knee	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
went	go	VBD	B-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
graft	graft	NN	B-NP	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
6	6	CD	I-NP	O
mm	mm	NN	I-NP	O
Dalcron	Dalcron	NN	I-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
postoperative	postoperative	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
popliteal	popliteal	NN	I-NP	O
and	and	CC	I-NP	O
graft	graft	NN	I-NP	O
pulse	pulse	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Dopplerable	Dopplerable	JJ	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulse	pulse	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ECG	ECG	NN	I-NP	B-protein
postoperatively	postoperatively	RB	B-ADVP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
preoperative	preoperative	JJ	I-NP	O
ECG	ECG	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
got	get	VBD	B-VP	O
very	very	RB	B-ADJP	O
diaphoretic	diaphoretic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nauseous	nauseous	JJ	I-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
an	an	DT	B-NP	O
ECG	ECG	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
throughout	throughout	IN	B-PP	O
that	that	DT	B-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
instability	instability	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
having	have	VBG	B-VP	O
gotten	get	VBN	I-VP	O
up	up	RP	B-PRT	O
rather	rather	RB	B-ADVP	O
quickly	quickly	RB	I-ADVP	O
and	and	CC	I-ADVP	O
likely	likely	RB	I-ADVP	O
a	a	DT	B-NP	O
vasovagal	vasovagal	JJ	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
course	course	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
mobilized	mobilize	VBN	I-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Dopplerable	Dopplerable	JJ	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulse	pulse	NN	I-NP	O
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
peroneal	peroneal	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
side	side	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
graft	graft	NN	I-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADJP	O
longer	longer	RBR	I-ADJP	O
palpable	palpable	JJ	I-ADJP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
strongly	strongly	RB	B-ADJP	O
Dopplerable	Dopplerable	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	B-cell_type
until	until	IN	B-PP	I-cell_type
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
reached	reach	VBD	B-VP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
1	1	CD	I-NP	O
level	level	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
on	on	IN	B-PP	O
1/25/99	1/25/99	CD	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
his	his	PRP$	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
for	for	IN	B-PP	O
keeping	keep	VBG	B-VP	O
the	the	DT	B-NP	O
graft	graft	NN	I-NP	O
patent	patent	NN	I-NP	O
and	and	CC	B-PP	O
not	not	RB	B-PP	O
for	for	IN	I-PP	O
any	any	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
or	or	CC	I-NP	O
stroke	stroke	JJ	I-NP	O
reasons	reason	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
approximately	approximately	RB	B-ADVP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/25/99	1/25/99	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
Dopplerable	Dopplerable	JJ	B-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulse	pulse	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
and	and	CC	O	O
peroneal	peroneal	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
record	record	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	B-NP	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
On	On	IN	B-PP	O
2/10/99	2/10/99	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	B-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
he	he	PRP	B-NP	O
got	get	VBD	B-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
5/27/99	5/27/99	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
got	get	VBD	B-VP	O
another	another	DT	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/17/99	8/17/99	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
got	get	VBD	B-VP	O
another	another	DT	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/15/99	10/15/99	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
got	get	VBD	B-VP	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/8/99	6/8/99	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
got	get	VBD	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
1/3/99	1/3/99	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
1/25/99	1/25/99	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
get	get	VB	I-VP	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
predicted	predict	VBN	I-NP	O
daily	daily	JJ	I-NP	O
dose	dose	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
roughly	roughly	RB	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
medicine	medicine	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
despite	despite	IN	B-PP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
CZI	CZI	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
over	over	IN	B-PP	O
201	201	CD	B-NP	O
to	to	TO	B-PP	O
250	250	CD	B-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
of	of	IN	B-PP	O
251	251	CD	B-NP	O
to	to	TO	B-PP	O
300	300	CD	B-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
of	of	IN	B-PP	O
301	301	CD	B-NP	O
to	to	TO	B-PP	O
350	350	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
351	351	CD	B-NP	O
to	to	TO	I-NP	O
400	400	CD	I-NP	O
and	and	CC	O	O
,	,	,	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
,	,	,	O	O
house	house	NN	B-NP	O
officer	officer	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Demerol	Demerol	NNP	B-NP	O
50	50	CD	I-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q4h	q4h	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Glucophage	Glucophage	NN	B-NP	B-protein
850	850	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
dosed	dose	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
daily	daily	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SAMUEL	SAMUEL	NNP	B-NP	O
NARD	NARD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JS07	JS07	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JUNIOR	JUNIOR	NNP	B-NP	O
VANSTROM	VANSTROM	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EA32	EA32	NNP	I-NP	O
TK273/9738	TK273/9738	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
5709	5709	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

VHTJGJ9M62	VHTJGJ9M62	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/1/99	9/1/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/1/99	9/1/99	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

REHABILITATION	REHABILITATION	NN	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
913	913	CD	I-NP	O
-RRB-	-RRB-	IN	B-PP	O
815-7095	815-7095	CD	B-NP	O

